This study aimed to evaluate in vitro and in vivo dietary supplementation with different levels of natural or nano-zeolite forms on rumen fermentation patterns and nutrient digestibility. In the in vitro experiment, a basal diet (50% concentrate: 50% forage) was incubated without additives (control) and with natural zeolite (10, 20, 30 g/kg DM) or nano-zeolite (0.2, 0.3, 0.4, 0.5, 1.0 g/kg DM) for 24 h to assess their effect on ruminal fermentation, feed degradability, and gas and methane production using a semi-automatic system of in vitro gas production (GP). The most effective doses obtained from the in vitro experiment were evaluated in vivo using 30 Barki goats (26 ± 0.9 SE kg body weight). Goats were allocated into three dietary treatments (n = 10/treatment) as follows: control (basal diet without any supplementations), natural zeolite (20 g/kg DM diet), and nano-zeolite (0.40 g/kg DM diet). The in vitro results revealed that only the nano-zeolite supplementation form quadratically (p= 0.004) increased GP, and the level of 0.5 g/kg DM had the highest GP value compared to the control. Both zeolite forms affected the CH₄ production, linear, and quadratic reductions (p < 0.05) in CH₄ (mL/g DM), consistent with linear increases in truly degraded organic matter (TDOM) (p = 0.09), and propionate molar proportions (p = 0.007) were observed by nano zeolite treatment, while the natural form of zeolite resulted in a linear CH₄ reduction consistent with a linear decrease (p = 0.004) in NH₃-N, linear increases in TDOM (p = 0.09), and propionate molar proportions (p = 0.004). Results of the in vivo experiment demonstrated that the nutrient digestibility was similar among all treatments. Nano zeolite enhanced (p < 0.05) the total short-chain fatty acids and butyrate concentrations, while both zeolite forms decreased (p < 0.001) NH₃-N compared to the control. These results suggested that both zeolite supplementation forms favorably modified the rumen fermentation in different patterns.

Gonadotropin-releasing hormone (GnRH)–loaded chitosan nanoparticles (GnRH–ChNPs) were used at different doses and routes of administration to induce ovulation in rabbits as an attempt to improve artificial insemination (AI) procedures and outcomes. In this study, the characteristics (size, polydispersity, loading efficiency, and zeta-potential) of GnRH–ChNPs and the GnRH release pattern were determined in an in vitro study. A first in vivo study assessed the pituitary and ovarian response to different GnRH–ChNPs doses and routes of administration (two i.m. doses, Group HM = 0.4 µg and Group QM = 0.2 µg, and two intravaginal doses, Group HV = 4 µg and Group QV = 2 µg) against a control group (C) receiving bare GnRH (0.8 µg). The HM, QM, and HV treatments induced an earlier LH-surge (90 min) than that observed in group C (120 min), whilst the QV treatment failed to induce such LH surge. The number of ovulation points was similar among treatments, except for the QV treatment (no ovulation points). A second in vivo study was consequently developed to determine the hormonal (progesterone, P₄, and estradiol, E₂) profile and pregnancy outcomes of both HM and HV treatments against group C. The treatment HM, but not the treatment HV, showed adequate P₄ and E₂ concentrations, conception and parturition rates, litter size, litter weight, and viability rate at birth. Overall, the use of GnRH–ChNPs allows for a reduction in the conventional intramuscular GnRH dose to half without compromising fertility. However, the addition of GnRH–ChNPs to semen extenders, although successfully inducing ovulation, has negative impacts on fertility. Thus, more studies are needed to explore this point and allow further adjustments.